{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:13:36Z","timestamp":1782782016559,"version":"3.54.5"},"reference-count":11,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1536\/ihj.16-361","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T22:07:37Z","timestamp":1494540457000},"page":"454-458","source":"Crossref","is-referenced-by-count":11,"title":["Identification of a Novel &lt;i&gt;GLA&lt;\/i&gt; Gene Mutation, p.Ile239Met, in Fabry Disease With a Predominant Cardiac Phenotype"],"prefix":"10.1536","volume":"58","author":[{"given":"Be\u00e1ta","family":"Cs\u00e1nyi","sequence":"first","affiliation":[{"name":"2nd Department of Internal Medicine and Cardiology Centre, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Hategan","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine and Cardiology Centre, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikt\u00f3ria","family":"Nagy","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine and Cardiology Centre, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella","family":"Ob\u00e1l","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edina T.","family":"Varga","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Borb\u00e1s","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine and Cardiology Centre, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annam\u00e1ria","family":"Tringer","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine and Cardiology Centre, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Eichler","sequence":"additional","affiliation":[{"name":"Centogene AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Forster","sequence":"additional","affiliation":[{"name":"Centogene AG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Rolfs","sequence":"additional","affiliation":[{"name":"Centogene AG"},{"name":"Albrecht-Kossel-Institute for Neuroregeneration, University of Rostock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Sepp","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine and Cardiology Centre, University of Szeged"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Germain DP. Fabry disease. Orphanet J Rare Dis 2010; 5: 30. (Review)","DOI":"10.1186\/1750-1172-5-30"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Elliott P, Baker R, Pasquale F, <i>et al<\/i>. Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease survey. Heart 2011; 97: 1957-60.","DOI":"10.1136\/heartjnl-2011-300364"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Smid BE, Hollak CE, Poorthuis BJ, <i>et al<\/i>. Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance. Clin Genet 2015; 88: 161-6.","DOI":"10.1111\/cge.12449"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Smid BE, van der Tol L, Cecchi F, <i>et al<\/i>. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. Int J Cardiol 2014; 177: 400-8. (Review)","DOI":"10.1016\/j.ijcard.2014.09.001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Richards S, Aziz N, Bale S, <i>et al<\/i>. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-24.","DOI":"10.1038\/gim.2015.30"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Lukas J, Scalia S, Eichler S, <i>et al<\/i>. Functional and clinical consequences of Novel <i>\u03b1<\/i>-Galactosidase A Mutations in Fabry Disease. Hum Mutat 2016; 37: 43-51.","DOI":"10.1002\/humu.22910"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kampmann C, Perrin A, Beck M. Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years\u2019 treatment. Orphanet J Rare Dis 2015; 10: 125.","DOI":"10.1186\/s13023-015-0338-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Elliott PM, Anastasakis A, Borger MA, <i>et al<\/i>. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-79.","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"9","unstructured":"9. Gersh BJ, Maron BJ, Bonow RO, <i>et al<\/i>. 2011 ACCF\/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: e212-60."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lukas J, Torras J, Navarro I, <i>et al<\/i>. Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene. Clin Kidney J 2012; 5: 395-400.","DOI":"10.1093\/ckj\/sfs115"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kotanko P, Kramar R, Devrnja D, <i>et al<\/i>. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol 2004; 15: 1323-9.","DOI":"10.1097\/01.ASN.0000124671.61963.1E"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/3\/58_16-361\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T14:07:02Z","timestamp":1569334022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/3\/58_16-361\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-361","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}